SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    YZ Shen, ZY Wang, TK Qi, XY Jiang, W Song, Y Tang, JR Wang, L Liu, RF Zhang, YF Zheng, ZS Dai, HZ Lu, Serological survey of viral hepatitis markers among newly diagnosed patients with HIV/AIDS in China, HIV Medicine, 2013, 14, 3
  2. 2
    Gregory J Dore, Vicente Soriano, Jürgen Rockstroh, Bernd Kupfer, Ellen Tedaldi, Lars Peters, Jacqueline Neuhaus, Massimo Puoti, Marina B Klein, Amanda Mocroft, Bonaventura Clotet, Jens D Lundgren, Frequent hepatitis B virus rebound among HIV–hepatitis B virus-coinfected patients following antiretroviral therapy interruption, AIDS, 2010, 24, 6, 857

    CrossRef

  3. 3
    E. Delarocque-Astagneau, C. Meffre, F. Dubois, C. Pioche, Y. Le Strat, F. Roudot-Thoraval, P. Hillon, C. Silvain, D. Dhumeaux, J. -C. Desenclos, The impact of the prevention programme of hepatitis C over more than a decade: the French experience, Journal of Viral Hepatitis, 2010, 17, 6
  4. 4
    Wendy A. Henderson, Jane M. Fall-Dickson, Elizabeth A. Schlenk, Kevin H. Kim, Judith T. Matthews, Judith A. Erlen, Effects of Liver Disease on the Well-Being of Persons Living With HIV, Journal of the Association of Nurses in AIDS Care, 2008, 19, 5, 368

    CrossRef

  5. 5
    Andrew D. Clouston, Julie R. Jonsson, Elizabeth E. Powell, Steatosis as a Cofactor in Other Liver Diseases: Hepatitis C Virus, Alcohol, Hemochromatosis, and Others, Clinics in Liver Disease, 2007, 11, 1, 173

    CrossRef

  6. 6
    Raphael B. Merriman, Nonalcoholic fatty liver disease and HIV infection, Current HIV/AIDS Reports, 2006, 3, 3, 113

    CrossRef

  7. 7
    Armando Sánchez-Quijano, Eduardo Lissen, Tratamiento de las hepatitis víricas (I). Tratamiento de la hepatitis crónica B, Enfermedades Infecciosas y Microbiología Clínica, 2006, 24, 7, 453

    CrossRef